2023-11-18 04:04:00
Title: Experts Discuss COVID-19 Vaccines and Long-Acting Immunization
As the COVID-19 outbreak continues to impact populations worldwide, experts are emphasizing the importance of vaccination and long-acting immunization to combat the virus.
Prof. Dr. Theeraphong Tantawichian, Assistant Director of Academic Affairs at the Saowabha Institute, Thai Red Cross Society, highlighted the emergence of the Omicron variant, noting that while it has decreased in severity, it spreads more efficiently and undergoes frequent mutations. He emphasized the need for booster vaccines to reduce the severity of the disease and hospital stays, especially for high-risk populations. The vaccine should also be accelerated for those who have never been vaccinated, as well as for individuals who have been infected but never received the vaccine.
Dr. Weerawat Manosutti, a qualified doctor from the Department of Disease Control, discussed the importance of long-acting immunization (LAAB) for immunocompromised patients, including those with chronic diseases, organ transplant recipients, and HIV patients. He emphasized the need for ready-made, long-acting immune injections, which can provide rapid immunity without the need for the body to build it. Dr. Manosutti also mentioned that a second generation of long-acting immunity is expected to be introduced in early 2024, offering enhanced protection and longer-lasting effects.
Overall, experts are urging the public to prioritize vaccination and long-acting immunization to mitigate the impact of COVID-19, especially as new variants continue to emerge. Vaccination efforts, particularly among vulnerable populations, are essential in the ongoing fight against the virus.]
#Groups #risk #COVID19 #vaccination #readymade #longacting #immunity